RT Journal Article
SR Electronic
T1 Prioritizing COVID-19 vaccination efforts and dose allocation within Madagascar
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.08.23.21262463
DO 10.1101/2021.08.23.21262463
A1 Rasambainarivo, Fidisoa
A1 Ramiadantsoa, Tanjona
A1 Raherinandrasana, Antso
A1 Randrianarisoa, Santatra
A1 Rice, Benjamin L.
A1 Evans, Michelle V.
A1 Roche, Benjamin
A1 Randriatsarafara, Fidiniaina Mamy
A1 Wesolowski, Amy
A1 Metcalf, C. Jessica
YR 2021
UL http://medrxiv.org/content/early/2021/08/25/2021.08.23.21262463.abstract
AB Background While mass COVID-19 vaccination programs are underway in high-income countries, limited availability of doses has resulted in few vaccines administered in low and middle income countries (LMICs). The COVID-19 Vaccines Global Access (COVAX) is a WHO-led initiative to promote vaccine access equity to LMICs and is providing many of the doses available in these settings. However, initial doses are limited and countries, such as Madagascar, need to develop prioritization schemes to maximize the benefits of vaccination with very limited supplies. There is some consensus that dose deployment should initially target health care workers, and those who are more vulnerable including older individuals. However, questions of geographic deployment remain, in particular associated with limits around vaccine access and delivery capacity in underserved communities, for example in rural areas that may also include substantial proportions of the population.Methods To address these questions, we developed a mathematical model of SARS-CoV-2 transmission dynamics and simulated various vaccination allocation strategies for Madagascar. Simulated strategies were based on a number of possible geographical prioritization schemes, testing sensitivity to initial susceptibility in the population, and evaluating the potential of tests for previous infection.Results Using cumulative deaths due to COVID-19 as the main outcome of interest, our results indicate that distributing the number of vaccine doses according to the number of elderly living in the region or according to the population size results in a greater reduction of mortality compared to distributing doses based on the reported number of cases and deaths. The benefits of vaccination strategies are diminished if the burden (and thus accumulated immunity) has been greatest in the most populous regions, but the overall strategy ranking remains comparable. If rapid tests for prior immunity may be swiftly and effectively delivered, there is potential for considerable gain in mortality averted, but considering delivery limitations modulates this.Conclusion At a subnational scale, our results support the strategy adopted by the COVAX initiative at a global scale.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFR is supported by Princeton High Meadows Environmental Institute; CJEM is supported by the Center for Health and Wellbeing, Princeton University.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets generated and analysed during the current study are available in the author s github repository https://www.github.com/fidyras/vaccination